Hunan Huateng Pharmaceutical Co., Ltd founded in 2013, is a one-stop a contract development and manufacturing organization (CDMO) to manufacture and supply researchers with PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. See more

Basic Information

Huateng Pharma has established a 5000 square meters R&D center , equipped with nearly 100 sets of high-end analytical and testing instruments and automatic reaction equipment, such as 400 MHz NMR system, Agilent LC/MS, Waters HPLC, Agilent Intelligent GC system, etc., which can ensure fast and efficient completion of various customized orders from customers. Huateng Pharma employs more than 400 full time staff, including more than 160 professional researchers of which approximately 60% are Ph.D.'s and MSc's. See more

Legal Name

:

Hunan Huateng Pharmaceutical Co Ltd

Headquarters

:

Changsha, Hunan, China

Business Model

:

B2B 

Founding Date

:

2013

No. of Employees

:

251 to 500

Core Team

:
1.

Deng Zeping

Founder

Timeline
2019
true
Sep | Raised Funding
Huateng Pharmaceutical Raised 50 Million Yuan in the Series A Round of Funding.
2021
Apr | Raised Funding
Huateng Pharma Completed Series B Round of Financing.

Revenue Streams

Target Market

B2B

A one-stop a contract development and manufacturing organization (CDMO) to manufacture and supply researchers with PEG derivatives and products used across the pharmaceutical value chain.

Client Segment

:

BioTech/BioPharmaceutical, Life Sciences

Target Companies

:

Startup, Small Enterprise, Medium Enterprise, Large Enterprise

Funding

Total Funding

$26.0M

Investors

:

1.

CITIC Securities